DNA X amends 8-K to de-classify its share-based acquisition as not significant

DNA X, Inc.

Company determined that its acquisition of DNA X LLC for 223,201 shares (19.99% stake) is not a 'significant amount of assets' under SEC rules.
As a result, financial statements and pro forma information required by Item 9.01 will not be provided for the transaction.
Transaction was originally reported in December 2025; this amendment filed on March 2, 2026.
No other changes from the original report; prior disclosure of the deal itself remains unchanged.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.